Skip to main navigation Skip to search Skip to main content

The status of serum hepatitis B virus DNA in HBSAG-positive hepatocellular carcinoma.

  • M. L. Yu*
  • , W. L. Chuang
  • , T. Y. Chow
  • , S. C. Chen
  • , S. N. Lu
  • , Z. Y. Lin
  • , M. Y. Hsieh
  • , L. Y. Wang
  • , W. Y. Chang
  • *Corresponding author for this work
  • Kaohsiung Medical University

Research output: Contribution to journalJournal Article peer-review

1 Scopus citations

Abstract

To elucidate the status of serum hepatitis B virus (HBV) DNA in HBsAg-positive hepatocellular carcinoma (HCC), 100 type B chronic liver disease (CLD) patients and 19 HCC patients were studied. The positive rate of serum HBV DNA in HBeAg-positive CLD patients was significantly higher than that in HBeAg-negative CLD patients, and the correlation between the presence of serum HBV DNA and patients' age showed a negative trend. In contrast, the positive rates of serum HBV DNA in HCC patients were not related to the status of HBeAg and age, and the positive rate of serum HBV DNA in HBeAg-negative HCC patients was significantly higher than that in HBeAg-negative CLD patients. Nevertheless, the serum concentrations of HBV DNA in HCC patients were significantly lower than those in CLD patients. These results suggest that replication of HBV in HCC patients might differ from that in CLD patients, and that persistent low-level HBV replication might be related to the presence of HCC.

Original languageEnglish
Pages (from-to)466-470
Number of pages5
JournalKaohsiung Journal of Medical Sciences
Volume12
Issue number8
StatePublished - 08 1996
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'The status of serum hepatitis B virus DNA in HBSAG-positive hepatocellular carcinoma.'. Together they form a unique fingerprint.

Cite this